Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             103 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author index 2005
 15 S1 p. S81-S83
3 p.
 artikel
2 Keyword index 2005
 15 S1 p. S85-S86
2 p.
 artikel
3 P.4.11 Activation of brain indoleamine 2,3-dioxygenase (IDO) by cytokines: a model of depressive disorders? Moreau, M.
 2005
 15 S1 p. S80-
1 p.
 artikel
4 P.1.20 Activation of pyramidal cells in rat medial prefrontal cortex projecting to ventral tegmental area by exogenous 5-HT1A receptor activation Díaz-Mataix, L.
 2005
 15 S1 p. S17-S18
2 p.
 artikel
5 P.4.01 A functional NOS-III haplotype is associated with bipolar disorder Reif, A.
 2005
 15 S1 p. S72-S73
2 p.
 artikel
6 P.3.06 A glycogen synthase kinase 3-ß -50 T/CSNP influences long-term response to lithium salts in bipolar illness Pontiggia, A.
 2005
 15 S1 p. S56-S57
2 p.
 artikel
7 P.2.18 Altered physiological responses to stress in the olfactory bulbectomised rat: normalisation by chronic fl uoxetine treatment Roche, M.
 2005
 15 S1 p. S44-S45
2 p.
 artikel
8 P.1.27 An endogenous compound 1-methyl-1,2,3,4-tetrahydroisoquinolineprevents the morphine addiction in rat: the view on neurochemical mechanism of action Wąsik, A.
 2005
 15 S1 p. S22-S23
2 p.
 artikel
9 P.3.20 An fMRI study of the effect ofmethylphenidate on neurocognitive function in children with ADHD Halari, R.
 2005
 15 S1 p. S66-S67
2 p.
 artikel
10 P.3.07 Antipsychotic agents and neuromusculardysfunction Reznik, I.
 2005
 15 S1 p. S57-S58
2 p.
 artikel
11 P.3.05 Association and haplotype analaysis of90 single-nucleotide polymorphisms in mood disorders Maron, E.
 2005
 15 S1 p. S55-S56
2 p.
 artikel
12 P.1.32 Association between the serotonin transporter linked polymorphic region gene and response to tricyclic antidepressants Tsapakis, E.
 2005
 15 S1 p. S26-S27
2 p.
 artikel
13 P.1.24 A transmembrane calcium flux is requiredfor circadian clock gene rhythmicity in mammalian pacemaker neurons Lundkvist, G.
 2005
 15 S1 p. S20-S21
2 p.
 artikel
14 P.4.06 Behavioral modifications induced by dietary cholesterol in rats Micale, V.
 2005
 15 S1 p. S76-
1 p.
 artikel
15 P.4.09 Behavioural and neurochemical consequencesof sIRNA-induced knockdown of serotonin and dopamine transporters in the adult mouse brain: Implications for validation of novel antidepressant targets Thakker, D.R.
 2005
 15 S1 p. S78-S79
2 p.
 artikel
16 P.2.21 Behavioural investigation into the role of corticotropin releasing factor in the frontal cortex of rat brain Zieba, B.
 2005
 15 S1 p. S47-
1 p.
 artikel
17 P.1.05 Benzodiazepine-adrenergic receptorinteractions in the pathophysiology of major depression Minenko, S.
 2005
 15 S1 p. S6-S7
2 p.
 artikel
18 P.2.06 Central activation of corticotropin-releasing factor receptor type 1 and type 2 receptors results in distinct serotonergic, neuroendocrine and behavioural responses de Groote, L.
 2005
 15 S1 p. S35-S36
2 p.
 artikel
19 P.2.20 c-fos mRNA expression within the ratbrain after exposure to the elevated plus maze: effect of prior treatment with anxiogenic and anxiolytic drugs Troakes, C.
 2005
 15 S1 p. S46-S47
2 p.
 artikel
20 P.2.25 Characterisation of a caffeine-inducedmodel of insomnia in the rat Paterson, L.M.
 2005
 15 S1 p. S49-S50
2 p.
 artikel
21 P.3.14 Cholinergic modulation of memory, learning and visuospatial processes in healthy elderly volunteers Wezenberg, E.
 2005
 15 S1 p. S62-S63
2 p.
 artikel
22 P.1.21 Chronic antidepressant treatments reduce glutamate release and protein-protein interactions favoring formation of snare complex Popoli, M.
 2005
 15 S1 p. S18-S19
2 p.
 artikel
23 P.1.06 Chronic lithium treatment attenuatesmarkers of ageing in the hippocampus of C57BL/6 mice Shaldubina, A.
 2005
 15 S1 p. S8-
1 p.
 artikel
24 P.3.13 Clinical impact of CYP2D6 polymorphismin patients with Alzheimer's disease in therapy with donepezil Scordo, M.G.
 2005
 15 S1 p. S61-S62
2 p.
 artikel
25 P.3.09 Comparison of bone metabolism between patients with restrictive and bulimic type of anorexia nervosa Śmiech, A.
 2005
 15 S1 p. S58-S59
2 p.
 artikel
26 P.1.31 Constitutive dimerization of the histamineH3 receptor in living cells Morisset, S.
 2005
 15 S1 p. S25-S26
2 p.
 artikel
27 P.2.11 Crossbreeding studies with helpless “HIRouen” and “NH/Rouen” indicate that some phenotypic differences between the lines are related to the helpless trait El Yacoubi, M.
 2005
 15 S1 p. S39-S40
2 p.
 artikel
28 P.2.13 D3 dopamine receptor knockout mice: behavioral alteration in experimental models of anxiety Leggio, G.M.
 2005
 15 S1 p. S41-
1 p.
 artikel
29 P.3.17 Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the ÆSOP study Dazzan, P.
 2005
 15 S1 p. S64-S65
2 p.
 artikel
30 P.1.15 Differential alterations in GABAA receptorexpression and function induced by ethanol of hippocampal and cerebellar granule cells Carta, M.
 2005
 15 S1 p. S14-
1 p.
 artikel
31 P.4.10 Different response to a dexamethasone and prednisolone test in treatment-resistant depressed patients Juruena, M.F.
 2005
 15 S1 p. S79-S80
2 p.
 artikel
32 P.2.10 Discriminative stimulus propertiesof tianeptine: partial substitution by fluoxetine and 8-OH-DPAT Alici, T.
 2005
 15 S1 p. S38-S39
2 p.
 artikel
33 P.3.16 Dopaminergic modulation of processing of uncertainty: a fMRl challenge study with methylphenidate Nenadic, I.
 2005
 15 S1 p. S64-
1 p.
 artikel
34 P.3.18 Early course of schizophrenic disorders;results from a Dutch epidemiological study Veen, N.
 2005
 15 S1 p. S65-S66
2 p.
 artikel
35 P.1.08 Effect of fluoxetine on GABA(B) receptorexpression and function in the dorsal horn of the rat spinal cord Korzh, I.
 2005
 15 S1 p. S9-
1 p.
 artikel
36 P.1.10 Effect of St. John's wort (Hypericumperforatum) on cytochrome P-450 2C6, 2D2 and 3A1/2 in rats Dostalek, M.
 2005
 15 S1 p. S10-S11
2 p.
 artikel
37 P.4.03 Effect of the combinations of weak-opiate analgesics with antidepressants in the tail suspension test Berrocoso, E.
 2005
 15 S1 p. S74-
1 p.
 artikel
38 P.2.03 Effect of urocortin 2 on home cagebehaviors and serotonergic neurons in the dorsal raphe nucleus Staub, D.R.
 2005
 15 S1 p. S33-S34
2 p.
 artikel
39 P.2.17 Endocrine and immune changesfollowing chronic treatment with tiagabine and amisulpride in the olfactory bulbectomized rat model of depression Pistovcakova, J.
 2005
 15 S1 p. S44-
1 p.
 artikel
40 P.3.10 Ethanol-like effects of N-methyl-d-aspartatereceptors antagonist memantine, and its ability to prevent cue induced alcohol craving Tsoy, M.
 2005
 15 S1 p. S59-S60
2 p.
 artikel
41 P.2.23 Evidence for social recognition inC57BL/6J and A/J mice Malyshkin, A.A.
 2005
 15 S1 p. S48-S49
2 p.
 artikel
42 P.1.28 Excitatory effects of thyrotropin-releasing hormone (TRH) in the thalamus: evidence for a role in the switch between sleep and waking Broberger, C.
 2005
 15 S1 p. S23-S24
2 p.
 artikel
43 P.4.02 Functional genomics-based identificationand validation of therapeutic targets and molecular markers for treatment and diagnosis of Major Depression Arteta, D.
 2005
 15 S1 p. S73-
1 p.
 artikel
44 P.2.19 GABAB receptor positive modulation as a novel therapeutic approach to drug dependence: blockade of the rewarding and psychostimulant effects of cocaine Slattery, D.A.
 2005
 15 S1 p. S45-S46
2 p.
 artikel
45 P.1.25 Galantamine increases firing activity of dopaminergic neurons in the ventral tegmental area Schilström, B.
 2005
 15 S1 p. S21-S22
2 p.
 artikel
46 P.1.07 Glutamatergic aspects of psychosis in neurodevelopmental animal model: What can they teach us about schizophrenia? Skuba, I.
 2005
 15 S1 p. S8-S9
2 p.
 artikel
47 P.1.33 5-HT1A receptor activation inducesupregulation of GABAAR gene expression in neurones Zhang, Z.
 2005
 15 S1 p. S27-
1 p.
 artikel
48 P.1.13 Hyperactivity and altered dopaminergicfunction in FGF-2 knockout mice Bedogni, E.
 2005
 15 S1 p. S12-S13
2 p.
 artikel
49 P.1.11 Hyperforin inhibits serotonin uptake by activating non selective cation channels Treiber, K.
 2005
 15 S1 p. S11-S12
2 p.
 artikel
50 P.1.26 Identification of stress-regulated genes in the brain of two mouse strains that differ in the antidepressant responsiveness Tsolakidou, A.
 2005
 15 S1 p. S22-
1 p.
 artikel
51 P.1.04 Impacts of type I interferons (IFN-α andIFN-τ) and type II interferon (IFN-γ) on the kynurenine pathway in human uninfected or HIV-1 infected macrophages Manéglier, B.
 2005
 15 S1 p. S6-
1 p.
 artikel
52 P.2.14 Influence of NMDA-receptors blockator on the sleep-wakefulness cycle in cats Mchedlidze, O.
 2005
 15 S1 p. S41-S42
2 p.
 artikel
53 P.3.11 Intravenous infusion of allopregnanoloneinduces sedation in humans Van Broekhoven, F.
 2005
 15 S1 p. S60-
1 p.
 artikel
54 P.2.15 Kynurenic acid andN-acetylaspartylglutamate do not alter PPI in mice Pålsson, E.
 2005
 15 S1 p. S42-S43
2 p.
 artikel
55 P.1.12 MAO-A genotype interaction with environment (psychosocial factors) and risk for criminality and alcohol related problems Wargelius, H.
 2005
 15 S1 p. S12-
1 p.
 artikel
56 P.1.14 Modulation of the mesocortical dopaminergic system by prefrontal 5-HT1A receptors. Role in antipsychotic drug action Bortolozzi, A.
 2005
 15 S1 p. S13-S14
2 p.
 artikel
57 P.4.05 Morphologic changes of heart electric field in depressive patients treated with dosulepine Kitzlerová, E.
 2005
 15 S1 p. S75-S76
2 p.
 artikel
58 P.2.24 Naloxone administration partially prevents ethanol effects on the sleep-wakefulness cycle in rats Basishvili, T.
 2005
 15 S1 p. S49-
1 p.
 artikel
59 P.3.23 Naltrexone for treatment of heroindependence in Russia Egorova, V.
 2005
 15 S1 p. S69-
1 p.
 artikel
60 P.3.15 Neural correlates of distorted moralthinking in bipolar depression: a 3.0 T BOLD fMRl event-related study Radaelli, D.
 2005
 15 S1 p. S63-
1 p.
 artikel
61 P.3.01 Neurocognitive impairment in euthymic young adults with recurrent depression: a case-control comparison of major depression and bipolar-spectrum disorder Smith, D.J.
 2005
 15 S1 p. S52-S53
2 p.
 artikel
62 P.4.08 Neurophysins response to apomorphineand clonidine in major depression Scantamburlo, G.
 2005
 15 S1 p. S77-S78
2 p.
 artikel
63 P.2.16 Noradrenergic facilitation of shock-probe defensive burying in lateral septum Petre, C.O.
 2005
 15 S1 p. S43-
1 p.
 artikel
64 P.1.16 Novelty induces phosphorylation and phospho-acetylation of histone H3 in rat dentate gyrus granule neurons Chandramohan, Y.
 2005
 15 S1 p. S14-S15
2 p.
 artikel
65 P.1.03 N-terminal domain of Wolframin interactswith carboxypeptidase E Luuk, H.
 2005
 15 S1 p. S5-S6
2 p.
 artikel
66 P.2.12 Pharmacological validation of the mouse elevated horizontal rod (the Suok test) as a novel experimental model of anxiety: sensitivity to diazepam and pentylenetetrazole Kalueff, A.V.
 2005
 15 S1 p. S40-S41
2 p.
 artikel
67 P.3.03 Poststroke depression — diagnosis and treatment Djokic, G.
 2005
 15 S1 p. S54-S55
2 p.
 artikel
68 P.4.07 Potential antidepressant-like effect of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP), a potent and highly selective mGIuR5 antagonist Palucha, A.
 2005
 15 S1 p. S77-
1 p.
 artikel
69 P.3.22 Predictive factors of resistance to antidepressant treatment: results from a European multicentre study Oswald, P.
 2005
 15 S1 p. S68-S69
2 p.
 artikel
70 P.1.30 Proteins involved in the cell death induced by a fragment of APP Madeira, A.
 2005
 15 S1 p. S25-
1 p.
 artikel
71 P.1.22 Proteomic search for intracellular bindingsites of antidepressants Kirmeier, T.
 2005
 15 S1 p. S19-
1 p.
 artikel
72 P.3.08 Quantification of serotonin transporterswith [123I]ADAM and SPECT in healthy human subjects: preliminary data on tracer kinetics Sacher, J.
 2005
 15 S1 p. S58-
1 p.
 artikel
73 P.3.19 Quantification of striatal D2 receptoroccupancy in bipolar patients treated with olanzapine using [123I] lodobenzamide and SPECT Attarbaschi, T.
 2005
 15 S1 p. S66-
1 p.
 artikel
74 P.2.05. Rats reared in social isolation displaydisrupted ppi and elevated levels of kynurenic acid in the hippocampus Erhardt, S.
 2005
 15 S1 p. S34-S35
2 p.
 artikel
75 P.3.12 Recovery from bipolar depression aftertotal sleep deprivation: a 3.0 T BOLD fMRl event-related study of moral thinking Bernasconi, A.
 2005
 15 S1 p. S61-
1 p.
 artikel
76 P.1.17 Regulation of synaptic transmission inthe striatum by protein kinases Chergui, K.
 2005
 15 S1 p. S15-S16
2 p.
 artikel
77 P.2.08 Role of the cannabinoid cb1 receptorantagonist sr 141716a in relapse to heroin seeking Fattore, L.
 2005
 15 S1 p. S37-
1 p.
 artikel
78 P.1.01 Schizophrenia-associated-proteins ina neurodevelopmentally rat model of schizophrenia Carmit, N.
 2005
 15 S1 p. S3-S4
2 p.
 artikel
79 P.2.07 Selecting over-active extremes in outbred heterogeneous stock (HS) mice for gene expression profiling: nominating novel candidate genes for over-activity Liu, L.
 2005
 15 S1 p. S36-S37
2 p.
 artikel
80 P.1.18 Serotonin receptors expression in glutamatergic and GABAergic cells in human and monkey prefrontal cortex de Almeida, J.
 2005
 15 S1 p. S16-
1 p.
 artikel
81 P.1.09 Stabilization of mitochondrial function bystandardized Ginkgo biloba extract Keil, U.
 2005
 15 S1 p. S10-
1 p.
 artikel
82 P.2.22 Strain related gender differences incortical 5-HT autoreceptor responses to sub-chronic fluoxetine Shalom, G.
 2005
 15 S1 p. S47-S48
2 p.
 artikel
83 P.4.04 Substitution of venlafaxine by fluoxetine and tianeptine in a conditioned taste aversion paradigm Kayir, H.
 2005
 15 S1 p. S74-S75
2 p.
 artikel
84 P.1.29 Subtype dependent changes of α1-adrenoceptormRNAs expression in the rat prefrontal cortex induced by the chronic mild stress procedure Bielawski, A.
 2005
 15 S1 p. S24-S25
2 p.
 artikel
85 P.3.04 Sumatriptan effect on regional brainperfusion: predicting therapeutic response in OCD Harary, E.
 2005
 15 S1 p. S55-
1 p.
 artikel
86 P.1.02 The effect of chronic lithium and lithium withdrawal on ventral tegmental area dopaminergic function Ferrie, L.J.
 2005
 15 S1 p. S4-S5
2 p.
 artikel
87 P.3.21 The effect of clozapine on factorscontrolling glucose homeostasis Howes, O.D.
 2005
 15 S1 p. S67-S68
2 p.
 artikel
88 P.2.01 The effects of altering dietary L-tryptophan on the performance of an iterated Prisoner's Dilemma (PD) game in healthy volunteers Wood, R.M.
 2005
 15 S1 p. S32-
1 p.
 artikel
89 P.2.02 The 5-HT1A and GABAA-benzodiazepine receptors: Effects in behavior and pharmacology in female 5-HT1A knockout mice Van Bogaert, M.J.V.
 2005
 15 S1 p. S32-S33
2 p.
 artikel
90 P.1.23 The long-term paraquat administration produces a slowly progressing degeneration of the nigrostriatal system in rats Kuter, K.
 2005
 15 S1 p. S20-
1 p.
 artikel
91 P.2.09 The paracapsular cells of the amgydala: an inhibitory network under dopaminergic control Marowsky, A.
 2005
 15 S1 p. S38-
1 p.
 artikel
92 P.1.19 The role of brain derived neurotropic factor (BDNF) in anorexia nervosa and hyperactivity de Krom, M.
 2005
 15 S1 p. S16-S17
2 p.
 artikel
93 P.2.04 The role of the melanocortin sytem in visceral pain Geerse, G.J.
 2005
 15 S1 p. S34-
1 p.
 artikel
94 P.3.02 The time course of neuropsychiatric symptoms induced by pegylated interferon-alpha-2b and ribavirin treatment for hepatitis C: a follow-up study Bull, S.J.H.
 2005
 15 S1 p. S53-S54
2 p.
 artikel
95 P.3.24 Volumes of brain structures in twinsdiscordant for bipolar disorder van der Schot, A.C.
 2005
 15 S1 p. S69-S70
2 p.
 artikel
96 S.2.1 Behavioral correlates of neurotransmitterfunction in depression Artigas, F.
 2005
 15 S1 p. S29-S30
2 p.
 artikel
97 S.4.2 Bipolar disorder Goodwin, G.M.
 2005
 15 S1 p. S71-S72
2 p.
 artikel
98 S.3.1 Clinical neuropsychopharmacology: focuson depression imaging in clinical research Mayberg, H.S.
 2005
 15 S1 p. S51-
1 p.
 artikel
99 S.3.2 Endophenotypes for affective disorders Modell, S.
 2005
 15 S1 p. S51-S52
2 p.
 artikel
100 S.1.1 Genetic approaches to psychiatricdiseases Goldman, D.
 2005
 15 S1 p. S1-S2
2 p.
 artikel
101 S.1.2 Molecular concepts: histone modificationsto investigate the impact of stress on the brain Reul, J.M.H.M.
 2005
 15 S1 p. S2-S3
2 p.
 artikel
102 S.2.2 Neuropsychopharmacology: bridginganimal and human studies Blier, P.
 2005
 15 S1 p. S30-S31
2 p.
 artikel
103 S.4.1 Neurotrophins and antidepressant drugaction Castrén, E.
 2005
 15 S1 p. S71-
1 p.
 artikel
                             103 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland